CN112159434A — 枸橼酸焦磷酸铁配合物的制备方法
Assigned to Beijing Fengrui Pharmaceutical Technology Co ltd · Expires 2021-01-01 · 5y expired
What this patent protects
本发明涉及一种枸橼酸焦磷酸铁配合物的制备方法,所述方法,包括以下步骤:取枸橼酸盐2.941g,焦磷酸盐2.23g‑3.13g,硫酸铁2.523g加入45ml水中;0‑35℃搅拌至完全溶解,搅拌下反应2‑6小时,得深绿色溶液;温度保持在0‑35℃,搅拌下将析晶剂缓慢滴加至深绿色溶液中,滴加完全后,继续搅拌析晶1‑2小时,得浅绿色沉淀,抽滤,固体干燥15‑20小时即得枸橼酸焦磷酸混配络合物。
USPTO Abstract
本发明涉及一种枸橼酸焦磷酸铁配合物的制备方法,所述方法,包括以下步骤:取枸橼酸盐2.941g,焦磷酸盐2.23g‑3.13g,硫酸铁2.523g加入45ml水中;0‑35℃搅拌至完全溶解,搅拌下反应2‑6小时,得深绿色溶液;温度保持在0‑35℃,搅拌下将析晶剂缓慢滴加至深绿色溶液中,滴加完全后,继续搅拌析晶1‑2小时,得浅绿色沉淀,抽滤,固体干燥15‑20小时即得枸橼酸焦磷酸混配络合物。
Drugs covered by this patent
- Triferic (FERRIC PYROPHOSPHATE CITRATE) · Rockwell Medical Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.